ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

Treat & Extend Versus Fixed Dosing With Faricimab for Management of Diabetic Macular Edema: A Pragmatic, Multi-center, Open-label, Randomized, Controlled Trial

ClinicalTrials.gov ID: NCT05610319

Public ClinicalTrials.gov record NCT05610319. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT05610319
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
McMaster University
Other
Enrollment
446 participants

Conditions and interventions

Interventions

  • Faricimab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2023
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Apr 16, 2026

2023 – 2026

United States locations

U.S. sites
11
U.S. states
5
U.S. cities
10
Facility City State ZIP Site status
Retinal Consultants Medical Group Inc. Modesto California 95356
Vitreo-Retina Medical Group Sacramento California 95825
University Retina and Macula Associates Oak Forest Illinois 60452
Eye Associates of Northeast Louisiana Dba Haik Humble Eye Center West Monroe Louisiana 71291
Mississippi Retina Associates Jackson Mississippi 39202
Austin Retina Associates Austin Texas 78705
Retina Consultants of Texas Beaumont Texas 77707
Retina & Vitreous of Texas Bellaire Texas 77401
Retina Consultants of Houston, dba Retina Consultants of Texas Bellaire Texas 77401
Valley Retina Institute McAllen Texas 78503
Retina Consultants of Houston, dba Retina Consultants of Texas San Antonio Texas 78240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05610319, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05610319 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →